PP
About
PMV Pharma is developing first-in-class p53 and p53 pathway modulators for the treatment of cancer. Bringing together leaders in the field to utilize over three decades of p53 biology, PMV Pharma combines unique biological understanding with pharmaceutical development focus.
Position in the VCSift Database
- • 3,884 investors in VCSift focus on the healthtech sector.
- • 166 investors are based in Redwood City, California, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Sectors
- healthtech biotech
- Location
- Redwood City, US
Contact Information
Find more investors like PMV
Search Investors